Other
Pharmacogenomics Testing
Pharmacogenomics Testing is an intervention with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (50.0%)
N/A1 (50.0%)
Trials by Status
completed133%
unknown133%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
completed
Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)
NCT05504135
terminatednot_applicable
The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients
NCT04251520
unknownphase_3
Pharmacogenetics for Pain Management in Joint Replacement Patients
NCT03772535
Clinical Trials (3)
Showing 3 of 3 trials
NCT05504135
Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)
NCT04251520Not Applicable
The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients
NCT03772535Phase 3
Pharmacogenetics for Pain Management in Joint Replacement Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3